Rachel Ames

Rachel Ames has a diverse work experience spanning over several years. Rachel is currently working as a Senior Scientist, Discovery Biology at RAPT Therapeutics, a role they have held since January 2022. Prior to this, they served as a Scientist II, Discovery Biology at the same company from September 2019 to February 2022. Rachel also worked as a Scientist I at Dynavax Technologies from January 2019 to September 2019.

Before transitioning into industry, Rachel gained research experience at various academic institutions. Rachel worked as a Postdoctoral Fellow at The University of Texas at Austin from May 2017 to December 2018. Prior to this, they were a Postdoctoral Fellow at Albert Einstein College of Medicine, where they also completed their graduate studies. Rachel'srole at Albert Einstein College of Medicine involved investigating T cell exhaustion and its transcriptional control and functional consequences using in vitro assays and an in vivo infection model. Rachel successfully defended their thesis in November 2015. Rachel also served as a Teaching Assistant for the Graduate Microbial Pathogenesis course from August 2012 to December 2012.

Rachel's earlier research experience includes working as a Laboratory Technician at Massachusetts General Hospital Cancer Center, specifically in the laboratories of Dr. Jeffrey Settleman, PhD, and Dr. Michael Seiden, MD PhD. Rachel'swork involved assessing protein expression and IL-6 production in ovarian cancer cell lines. Rachel also worked as an Undergraduate Researcher at Boston University School of Medicine in the laboratory of Dr. Douglas Rosene, MD PhD.

Overall, Rachel Ames has demonstrated expertise in discovery biology, T cell tolerance, and ovarian cancer research throughout their professional career.

Rachel Ames completed their Bachelor of Arts (B.A.) degree in Biochemistry and Molecular Biology from Boston University between 2002 and 2006. Rachel pursued further education at Albert Einstein College of Medicine from 2008 to 2015 and obtained their Doctor of Philosophy (Ph.D.) degree in Biomedical Sciences with a specialization in Immunology.